Cargando…
TRIM37 targets AKT in the growth of lung cancer cells
BACKGROUND: TRIM37 is an ubiquitin E3 ligase. Growing evidence has demonstrated the high value of TRIM37 as a potential biomarker for diagnosis of certain cancers. However, the biological function of TRIM37 in lung cancer is still unknown. MATERIALS AND METHODS: In order to gain a deep insight into...
Autores principales: | Dong, Shumin, Pang, Xueqin, Sun, Haijun, Yuan, Chunluan, Mu, Chuanyong, Zheng, Shiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231437/ https://www.ncbi.nlm.nih.gov/pubmed/30510432 http://dx.doi.org/10.2147/OTT.S183303 |
Ejemplares similares
-
TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
por: Brigant, Benjamin, et al.
Publicado: (2018) -
TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer
por: Hu, Cheng-En, et al.
Publicado: (2017) -
Silencing TRIM37 inhibits the proliferation and migration of non-small cell lung cancer cells
por: Ding, Yi, et al.
Publicado: (2018) -
TRIM37 interacts with PTEN to promote the growth of human T-cell acute lymphocytic leukemia cells through regulating PI3K/AKT pathway
por: Qu, Honglan, et al.
Publicado: (2023) -
TRIM37 controls cancer-specific vulnerability to PLK4 inhibition
por: Meitinger, Franz, et al.
Publicado: (2020)